The EU AI Pact supports organizations in preparing for the EU AI Act, the world’s first comprehensive AI law. Joining the AI Pact reinforces ArisGlobal’s belief in a future underpinned by responsible AI.
BOSTON, Feb. 12, 2025 /PRNewswire/ — ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, today announced its official signing of the European Union’s AI Pact agreement. The public pledge promotes responsible and ethical AI development and deployment, underpinning AI’s “bigger picture”: its benefits to society.
The AI Pact is a voluntary framework created by the European Commission to help stakeholders prepare for the implementation of the EU AI Act. It is the first comprehensive regulation on AI by a major regulator globally.
By making this pledge, ArisGlobal is publicly confirming its commitment to uphold the highest standards and best practices related to AI governance, ethics, and responsibility. This will ensure that its life sciences clients can trust the benefits delivered by the technology, for instance in the form of new or honed patient safety insights.
ArisGlobal has signed the Pact as a demonstration of its commitment to customers of its LifeSphere Regulatory and Safety platform, powered by its advanced cognitive computing engine, NavaX.
By participating in the initiative, ArisGlobal is committing to:
Jason Bryant, ArisGlobal’s Vice President of Product Management for AI & Data, said, “At ArisGlobal, we believe that AI should benefit society, which isn’t possible without ethical AI practices. We take responsible AI very seriously. That is both via our leadership position in the industry, and as we apply the technology to deliver advanced insight – allowing our customers to make better decisions that feed into patient safety. Joining the AI Pact reinforces our commitment, and our belief in a future underpinned by responsible AI.”
He added, “Our progress will be as visible as our commitment. We will report on our performance against our core promises, as well as additional approaches we’ll be taking to drive best-of-breed industry behavior.”
About ArisGlobal
ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan, and China. For more updates, follow ArisGlobal on LinkedIn or visit arisglobal.com.
SOURCE ArisGlobal
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at…
LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…
Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…
Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…
Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving…
Independent report examines Calm Nature CBD Gummies full spectrum formulation, CO2 extraction claims, THC removal…